Guangzhou BeBetter Med Co., Ltd
Guangzhou BeBetter Med Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia | B-cell Precursor Acute Lymphoblastic Leukemia (ALL) | Recruiting | Phase 1 | 2026-10-02 | NCT07854652 |